BioCentury | Sep 26, 2018
Distillery Therapeutics

Neurology

INDICATION: Neurology Mouse models suggest clearing senescent cells could help treat tau-mediated neurodegenerative diseases. In a mouse model of tauopathy expressing mutant human tau in neurons, systemic expression of a fusion human transgene based on...
BioCentury | Aug 17, 2018
Targets & Mechanisms

RNA party

A study in Cell has uncovered a brain regulatory network involving a circular RNA, a long non-coding RNA and two microRNAs, and could provide some much needed insights in a field where finding links to...
BioCentury | Nov 16, 2017
Tools & Techniques

Yeast against aggregation

In drug discovery for neurodegenerative diseases, the emphasis is on finding better models of neuronal systems that recapitulate synapses, neuroinflammation and the pathological accumulation of toxic aggregates. Yumanity Therapeutics LLC and a handful of academic...
BioCentury | Jan 8, 2014
Financial News

Aldexa files for IPO

...up to $20.8 million in an IPO underwritten by Aegis Capital. This year, Aldexa (formerly Neuron Systems Inc....
BioCentury | Mar 19, 2012
Company News

Neuron Systems, pSivida deal

...with compounds from Neuron to treat dry age-related macular degeneration (AMD). Details were not disclosed. Neuron Systems Inc....
BioCentury | Jan 2, 2012
Finance

Into the gap

...1999 and spun back out in 2002. He most recently was CEO of ophthalmology company Neuron Systems Inc....
BioCentury | Mar 19, 2007
Product Development

Antidepression triad

Although sanofi-aventis Group has not hidden the fact it has moved three antidepressant and anxiolytic molecules into late-stage development, it has revealed few details. Now, the company is beginning to lift the veil, describing the...
BioCentury | Jun 13, 1994
Company News

Layton, Stratagene Cloning Systems Inc. deal

Layton (Atherton, Calif.) granted La Jolla-based Strategene exclusive marketing rights to Layton's hNT human neuronal cells for research use in the U.S., Canada and Europe. Layton said the hNT neurons will allow researchers to study...
Items per page:
1 - 8 of 8
BioCentury | Sep 26, 2018
Distillery Therapeutics

Neurology

INDICATION: Neurology Mouse models suggest clearing senescent cells could help treat tau-mediated neurodegenerative diseases. In a mouse model of tauopathy expressing mutant human tau in neurons, systemic expression of a fusion human transgene based on...
BioCentury | Aug 17, 2018
Targets & Mechanisms

RNA party

A study in Cell has uncovered a brain regulatory network involving a circular RNA, a long non-coding RNA and two microRNAs, and could provide some much needed insights in a field where finding links to...
BioCentury | Nov 16, 2017
Tools & Techniques

Yeast against aggregation

In drug discovery for neurodegenerative diseases, the emphasis is on finding better models of neuronal systems that recapitulate synapses, neuroinflammation and the pathological accumulation of toxic aggregates. Yumanity Therapeutics LLC and a handful of academic...
BioCentury | Jan 8, 2014
Financial News

Aldexa files for IPO

...up to $20.8 million in an IPO underwritten by Aegis Capital. This year, Aldexa (formerly Neuron Systems Inc....
BioCentury | Mar 19, 2012
Company News

Neuron Systems, pSivida deal

...with compounds from Neuron to treat dry age-related macular degeneration (AMD). Details were not disclosed. Neuron Systems Inc....
BioCentury | Jan 2, 2012
Finance

Into the gap

...1999 and spun back out in 2002. He most recently was CEO of ophthalmology company Neuron Systems Inc....
BioCentury | Mar 19, 2007
Product Development

Antidepression triad

Although sanofi-aventis Group has not hidden the fact it has moved three antidepressant and anxiolytic molecules into late-stage development, it has revealed few details. Now, the company is beginning to lift the veil, describing the...
BioCentury | Jun 13, 1994
Company News

Layton, Stratagene Cloning Systems Inc. deal

Layton (Atherton, Calif.) granted La Jolla-based Strategene exclusive marketing rights to Layton's hNT human neuronal cells for research use in the U.S., Canada and Europe. Layton said the hNT neurons will allow researchers to study...
Items per page:
1 - 8 of 8